The Effect of Relaxation Response Training on Declarative Memory and Salivary Cortisol in Older Adults

This study has been completed.
Sponsor:
Collaborator:
Mind/Body Medical Institute
Information provided by:
Beth Israel Deaconess Medical Center
ClinicalTrials.gov Identifier:
NCT00179530
First received: September 13, 2005
Last updated: November 2, 2007
Last verified: November 2007
  Purpose

To evaluate whether a 5-week relaxation response intervention influences the learning, memory or attention of healthy older adults.


Condition Intervention Phase
Healthy
Behavioral: Relaxation Response
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: The Effect of Relaxation Response Training on Declarative Memory and Salivary Cortisol in Older Adults

Resource links provided by NLM:


Further study details as provided by Beth Israel Deaconess Medical Center:

Primary Outcome Measures:
  • Evaluate whether a RR training program would decrease anxiety levels, improve attention, declarative memory performance in healthy older adults. [ Time Frame: 8 weeks ]

Secondary Outcome Measures:
  • Evaluate whether a RR training program would decrease salivary cortisol levels in healthy older adults. [ Time Frame: 8 weeks ]

Enrollment: 16
Study Start Date: May 1999
Study Completion Date: September 2007
Intervention Details:
    Behavioral: Relaxation Response
    Relaxation training
  Eligibility

Ages Eligible for Study:   65 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • 65 to 80 years od age
  • No prior or current psychiatric or neurological condition.
  • score above 24 on the Mini-Mental State Exam (MMSE)
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00179530

Sponsors and Collaborators
Beth Israel Deaconess Medical Center
Mind/Body Medical Institute
Investigators
Principal Investigator: Jeffery A Dusek, PhD Beth Israel Deaconess Medical Center, Mind/Body Medical Institute
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00179530     History of Changes
Other Study ID Numbers: 2001-P-002249
Study First Received: September 13, 2005
Last Updated: November 2, 2007
Health Authority: United States: Food and Drug Administration

Additional relevant MeSH terms:
Hydrocortisone
Anti-Inflammatory Agents
Therapeutic Uses
Pharmacologic Actions

ClinicalTrials.gov processed this record on April 17, 2014